PyInvesting

Market research

600521.SHG Zhejiang Huahai Pharmaceutical Co., Ltd

SHG CNY Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
25B
P/E ratio
69.25
Analyst target
18.2
Dividend yield
0.6%
Beta
0.13

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Zhejiang Huahai Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 25.8% below its 200 day moving average.

From a valuation standpoint, the stock is 39.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.8.

Zhejiang Huahai Pharmaceutical Co., Ltd's total revenue rose by 15.2% to $2B since the same quarter in the previous year.

Its net income has increased by 48.1% to $262M since the same quarter in the previous year.

Finally, its free cash flow fell by 70.2% to $133M since the same quarter in the previous year.

Based on the above factors, Zhejiang Huahai Pharmaceutical Co., Ltd gets an overall score of 3/5.